Skip to content

Released Nov 2, 2017, after the close

10-Q filed Nov 2, 2017, 33 days after period end · 0001558370-17-008004

Q3 2017 · 10-Q
Revenue$86.83M+31.3% vs Q3 2016+33.4% vs Q2 2017
Net Income-$32.30MN/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$0.22N/M vs Q3 2016N/M vs Q2 2017
Operating Income-$19,434,000N/M
Operating Cash Flowderived-$31,242,000N/M
Free Cash Flowderived-$32,705,000N/M
Margins · derived
Operating margin-22.4%+20.4 pt vs Q3 2016
Net margin-37.2%+13.0 pt vs Q3 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2017Q3 2016Q3 2015Q3 2014
Revenue$86.83M$66.11M$39.57M$16.92M
Net Income-$32.30M-$33.20M——
EPS Diluted-$0.22-$0.23-$0.33-$0.30

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR